| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |